Grant opportunity · PAR-25-065
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
Who can apply (as listed)
- City or township governments
- Public housing authorities / Indian housing authorities
- Private institutions of higher education
- County governments
- Others (see the opportunity text)
- Special district governments
- Native American tribal organizations (other than federally recognized governments)
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- State governments
- Public and state-controlled institutions of higher education
- Small businesses
- Independent school districts
- Native American tribal governments (federally recognized)
- For-profit organizations (other than small businesses)
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.